@article{929e3db88bc146548cd770360698a9ab,
title = "Improvement in Health-Related Quality of Life After Community Acquired Pediatric Septic Shock",
abstract = "Background: Although some pediatric sepsis survivors experience worsening health-related quality of life (HRQL), many return to their pre-illness HRQL. Whether children can improve beyond baseline is not known. We examined a cohort of pediatric sepsis survivors to determine if those with baseline HRQL scores below the population mean could exhibit ≥10% improvement and evaluated factors associated with improvement. Methods: In this secondary analysis of the Life After Pediatric Sepsis Evaluation prospective study, children aged 1 month to 18 years admitted to 12 academic PICUs in the United States with community-acquired septic shock who survived to 3 months and had baseline HRQL scores ≤ 80 (i.e., excluding those with good baseline HRQL to allow for potential improvement) were included. HRQL was measured using the Pediatric Quality of Life Inventory or Stein-Jessop Functional Status Scale. Findings: One hundred and seventeen children were eligible. Sixty-one (52%) had ≥ 10% improvement in HRQL by 3 months. Lower pre-sepsis HRQL was associated with increased odds of improvement at 3 months [aOR = 1.08, 95% CI (1.04–1.11), p < 0.001] and 12 months [OR = 1.05, 95% CI (1.02–1.11), p = 0.005]. Improvement in HRQL was most prevalent at 3 month follow-up; at 12 month follow-up, improvement was more sustained among children without severe developmental delay compared to children with severe developmental delay. Interpretation: More than half of these children with community acquired septic shock experienced at least a 10% improvement in HRQL from baseline to 3 months. Children with severe developmental delay did not sustain this improvement at 12 month follow-up.",
keywords = "PICU, health-related quality of life, long-term outcomes, pediatric critical care, pediatric critical illness, pediatric sepsis, survivorship",
author = "{the Life After Pediatric Sepsis Evaluation (LAPSE) Investigators} and Pinto, {Neethi P.} and Berg, {Robert A.} and Zuppa, {Athena F.} and Newth, {Christopher J.} and Pollack, {Murray M.} and Meert, {Kathleen L.} and Hall, {Mark W.} and Michael Quasney and Anil Sapru and Carcillo, {Joseph A.} and McQuillen, {Patrick S.} and Mourani, {Peter M.} and Chima, {Ranjit S.} and Richard Holubkov and Nadkarni, {Vinay M.} and Reeder, {Ron W.} and Zimmerman, {Jerry J.}",
note = "Funding Information: The LAPSE Investigators acknowledge the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services for its financial support of the study. The LAPSE Investigators thank all subjects and families for participating in the LAPSE investigation. Following is a summary of LAPSE Performance Sites, Principal Investigators (PI), Co-investigators (CI), Research Coordinators (RC), and Allied Research Personnel. Children{\textquoteright}s Hospital of Michigan, Detroit, MI: Kathleen L. Meert (PI); Sabrina Heidemann (CI); Ann Pawluszka (RC); Melanie Lulic (RC). Children{\textquoteright}s Hospital of Philadelphia, Philadelphia, PA: Robert A. Berg (PI); Athena Zuppa (CI); Carolann Twelves (RC); Mary Ann DiLiberto (RC). Children{\textquoteright}s National Medical Center, Washington, DC: Murray Pollack (PI); David Wessel (PI); John Berger (CI); Elyse Tomanio (RC); Diane Hession (RC); Ashley Wolfe (RC). Children{\textquoteright}s Hospital of Colorado, Aurora, CO: Peter M. Mourani (PI); Todd Carpenter (CI); Diane Ladell (RC); Yamila Sierra (RC); Alle Rutebemberwa (RC). Nationwide Children{\textquoteright}s Hospital, Columbus, OH: Mark W. Hall (PI); Andrew Yates (CI); Lisa Steele (RC); Maggie Flowers (RC); Josey Hensley (RC). Mattel Children{\textquoteright}s Hospital, University of California Los Angeles, Los Angeles, CA: Anil Sapru (PI); Rick Harrison (CI), Neda Ashtari (RC); Anna Ratiu (RC). Children{\textquoteright}s Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA: Joe Carcillo (PI); Michael Bell (CI); Leighann Koch (RC); Alan Abraham (RC). Benioff Children{\textquoteright}s Hospital, University of California, San Francisco, San Francisco, CA: Patrick S. McQuillen (PI); Anne McKenzie (RC); Yensy Zetino (RC). Children{\textquoteright}s Hospital of Los Angeles, Los Angeles, CA: Christopher Newth (PI); Jeni Kwok (RC); Amy Yamakawa Funding Information: The LAPSE Investigators acknowledge the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services for its financial support of the study. The LAPSE Investigators thank all subjects and families for participating in the LAPSE investigation. Following is a summary of LAPSE Performance Sites, Principal Investigators (PI), Co-investigators (CI), Research Coordinators (RC), and Allied Research Personnel. Children's Hospital of Michigan, Detroit, MI: Kathleen L. Meert (PI); Sabrina Heidemann (CI); Ann Pawluszka (RC); Melanie Lulic (RC). Children's Hospital of Philadelphia, Philadelphia, PA: Robert A. Berg (PI); Athena Zuppa (CI); Carolann Twelves (RC); Mary Ann DiLiberto (RC). Children's National Medical Center, Washington, DC: Murray Pollack (PI); David Wessel (PI); John Berger (CI); Elyse Tomanio (RC); Diane Hession (RC); Ashley Wolfe (RC). Children's Hospital of Colorado, Aurora, CO: Peter M. Mourani (PI); Todd Carpenter (CI); Diane Ladell (RC); Yamila Sierra (RC); Alle Rutebemberwa (RC). Nationwide Children's Hospital, Columbus, OH: Mark W. Hall (PI); Andrew Yates (CI); Lisa Steele (RC); Maggie Flowers (RC); Josey Hensley (RC). Mattel Children's Hospital, University of California Los Angeles, Los Angeles, CA: Anil Sapru (PI); Rick Harrison (CI), Neda Ashtari (RC); Anna Ratiu (RC). Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA: Joe Carcillo (PI); Michael Bell (CI); Leighann Koch (RC); Alan Abraham (RC). Funding Information: Conflict of Interest: JC was funded by the NICHD and NIGMS. MH serves as a paid consultant to LaJolla Pharmaceuticals, and he receives licensing income from Kiadis. Both relationships are unrelated to the content of the current manuscript. RH serves on Data Safety Monitoring Boards for Pfizer, Inc. CN has had financial relationships with Philips Research North America, Hamilton Medical AG, and Nihon Kohden America. JZ has received compensation for the following activities: salary distribution from the University of Washington Medical Group and the Society of Critical Care Medicine (2018–2019 only); royalty payments from Elsevier Publishing for serving as Co-Editor for Pediatric Critical Care; research funding from the National Institutes of Health, Patient-Centered Outcomes Research Institute, Biomedical Advanced Research and Development Authority, and Immunexpress, Seattle; and travel reimbursement to attend board meetings from the Society of Critical Care Medicine. Funding Information: This investigation was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, R01HD073362, and was supported, in part, by the following Cooperative Agreements: UG1HD050096, UG1HD049981, UG1HD049983, UG1HD063108, UG1HD083171, UG1HD083166, UG1HD083170, U10HD050012, U10HD063106, and U01HD049934. The funders of the study did not participate in study design, data collection, data analysis, data interpretation, writing of the report, nor decision to submit the paper for publication. Publisher Copyright: {\textcopyright} Copyright {\textcopyright} 2021 Pinto, Berg, Zuppa, Newth, Pollack, Meert, Hall, Quasney, Sapru, Carcillo, McQuillen, Mourani, Chima, Holubkov, Nadkarni, Reeder, Zimmerman and the Life After Pediatric Sepsis Evaluation (LAPSE) Investigators.",
year = "2021",
month = aug,
day = "18",
doi = "10.3389/fped.2021.675374",
language = "English",
volume = "9",
journal = "Frontiers in Pediatrics",
issn = "2296-2360",
}